Showing results (31-40 of 331) with videos related to

Sort By:
Pageof 34
Cancer Research|March 1, 1996
Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding proteinP J Watkins, J P Condreay, B E Huber, et al.
Biochemical and Biophysical Research Communications|May 29, 1986
Induction by phenobarbital in McA-RH7777 rat hepatoma cells of a polycyclic hydrocarbon inducible cytochrome P450M E McManus, R F Minchin, D M Schwartz, et al.
Biochemical Pharmacology|July 5, 1991
Metabolism of a novel antitumor agent, crisnatol, by a human hepatoma cell line, Hep G2, and hepatic microsomes. Characterization of metabolitesD K Patel, J P Shockcor, S Y Chang, et al.
Science (New York, N.Y.)|May 29, 1987
Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liverS S Thorgeirsson, B E Huber, S Sorrell, et al.
Cancer Research|September 1, 1985
Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell lineB E Huber, K L Dearfield, J R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminaseB E Huber, E A Austin, C A Richards, et al.
Cancer Research|November 1, 1995
Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell lineQ T Trinh, E A Austin, D M Murray, et al.
Hepatology (Baltimore, Md.)|March 1, 1986
Studies of gene transcription and translation in regenerating rat liverB E Huber, C A Heilman, P J Wirth, et al.
The Journal of Biological Chemistry|December 25, 1987
Ligand-induced modulation of the hepatic receptor for asialoglycoproteins in the human hepatoblastoma cell line, Hep G2C J Steer, P Weiss, B E Huber, et al.
Cancer Research|October 1, 1993
In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminaseB E Huber, E A Austin, S S Good, et al.
Pageof 34